These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26315817)

  • 21. Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?
    Costantino L; Boraschi D
    Drug Discov Today; 2012 Apr; 17(7-8):367-78. PubMed ID: 22094246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Carrier Geometry in Overcoming Biological Barriers to Drug Delivery.
    Jordan C; Shuvaev VV; Bailey M; Muzykantov VR; Dziubla TD
    Curr Pharm Des; 2016; 22(9):1259-73. PubMed ID: 26675218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled pulmonary drug and gene delivery using polymeric nano-carriers.
    Beck-Broichsitter M; Merkel OM; Kissel T
    J Control Release; 2012 Jul; 161(2):214-24. PubMed ID: 22192571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons from nature: "Pathogen-Mimetic" systems for mucosal nano-medicines.
    Mrsny RJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):172-92. PubMed ID: 19146895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fate of nanocarriers as nanomedicines in vivo: important considerations and biological barriers to overcome.
    Moros M; Mitchell SG; Grazú V; de la Fuente JM
    Curr Med Chem; 2013; 20(22):2759-78. PubMed ID: 23627938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimuli-responsive nanocarriers for delivery of bone therapeutics - Barriers and progresses.
    Lavrador P; Gaspar VM; Mano JF
    J Control Release; 2018 Mar; 273():51-67. PubMed ID: 29407678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.
    Gan L; Wang J; Jiang M; Bartlett H; Ouyang D; Eperjesi F; Liu J; Gan Y
    Drug Discov Today; 2013 Mar; 18(5-6):290-7. PubMed ID: 23092895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles and microparticles for skin drug delivery.
    Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS
    Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting.
    Feng Q; Shen Y; Fu Y; Muroski ME; Zhang P; Wang Q; Xu C; Lesniak MS; Li G; Cheng Y
    Theranostics; 2017; 7(7):1875-1889. PubMed ID: 28638474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in nanocarrier-loaded gels: Which drug delivery technologies against which diseases?
    Pitorre M; Gondé H; Haury C; Messous M; Poilane J; Boudaud D; Kanber E; Rossemond Ndombina GA; Benoit JP; Bastiat G
    J Control Release; 2017 Nov; 266():140-155. PubMed ID: 28951319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transport barriers and strategies of antitumor nanocarriers delivery system.
    Zhang L; Wang Y; Cao Y; Lou D; Wang B
    J Biomed Mater Res A; 2013 Dec; 101(12):3661-9. PubMed ID: 23983207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organic nanocarriers for cancer drug delivery.
    López-Dávila V; Seifalian AM; Loizidou M
    Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and Perspectives.
    Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
    Curr Pharm Des; 2017; 23(22):3301-3308. PubMed ID: 28403792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
    Pignatello R; Carbone C; Puglia C; Offerta A; Bonina FP; Puglisi G
    Ther Deliv; 2015; 6(11):1297-318. PubMed ID: 26608630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.
    Bisht R; Mandal A; Jaiswal JK; Rupenthal ID
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28425224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on the role of nanovehicles in nose-to-brain drug delivery.
    Feng Y; He H; Li F; Lu Y; Qi J; Wu W
    Drug Discov Today; 2018 May; 23(5):1079-1088. PubMed ID: 29330120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Core-shell nanocarriers for cancer therapy. Part I: biologically oriented design rules.
    d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
    Expert Opin Drug Deliv; 2014 Feb; 11(2):283-97. PubMed ID: 24313282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.